- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
92
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
92 companies
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$118.5b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$508.00
7D
-0.4%
1Y
200.1%
Lee's Pharmaceutical Holdings
Market Cap: HK$1.4b
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$2.30
7D
-8.4%
1Y
93.3%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.14
7D
-1.4%
1Y
62.1%
Sanai Health Industry Group
Market Cap: HK$62.7m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.41
7D
-5.7%
1Y
86.4%
Innovent Biologics
Market Cap: HK$162.8b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$95.05
7D
-2.4%
1Y
112.2%
Medtide
Market Cap: HK$4.3b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$30.66
7D
-2.1%
1Y
n/a
JW (Cayman) Therapeutics
Market Cap: HK$1.7b
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$4.14
7D
-18.2%
1Y
202.2%
PegBio
Market Cap: HK$15.6b
A biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China.
2565
HK$55.90
7D
7.7%
1Y
n/a
Guangzhou Innogen Pharmaceutical Group
Market Cap: HK$19.1b
Engages in development of drugs.
2591
HK$41.78
7D
-4.0%
1Y
n/a
Sunshine Lake Pharma
Market Cap: HK$28.9b
Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.
6887
HK$50.05
7D
-0.4%
1Y
53.1%
Duality Biotherapeutics
Market Cap: HK$28.6b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$325.00
7D
-29.8%
1Y
n/a
Hansoh Pharmaceutical Group
Market Cap: HK$215.3b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$35.56
7D
-1.1%
1Y
76.9%
Hangzhou Jiuyuan Genetic Biopharmaceutical
Market Cap: HK$2.7b
A biopharmaceutical company, engages in the research, development, production, and sale of biopharmaceutical products and medical devices.
2566
HK$11.13
7D
-10.5%
1Y
n/a
3D Medicines
Market Cap: HK$1.8b
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.
1244
HK$7.50
7D
-7.3%
1Y
177.8%
CSPC Pharmaceutical Group
Market Cap: HK$106.3b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.30
7D
-8.3%
1Y
70.3%
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$4.5b
A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.
1541
HK$11.15
7D
-3.5%
1Y
123.0%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$478.2m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.42
7D
-7.6%
1Y
123.7%
Tong Ren Tang Technologies
Market Cap: HK$6.1b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.80
7D
-2.6%
1Y
-7.3%
Everest Medicines
Market Cap: HK$20.2b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$57.15
7D
-3.0%
1Y
127.7%
Jacobio Pharmaceuticals Group
Market Cap: HK$7.2b
An investment holding company, engages in the in-house discovery and development of oncology therapies.
1167
HK$9.15
7D
-15.2%
1Y
419.9%
Sunho Biologics
Market Cap: HK$1.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems.
2898
HK$7.94
7D
1.0%
1Y
53.9%
Genscript Biotech
Market Cap: HK$34.7b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$15.88
7D
-7.9%
1Y
40.5%
CStone Pharmaceuticals
Market Cap: HK$11.4b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$7.81
7D
-10.0%
1Y
420.7%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$255.1m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.15
7D
-0.7%
1Y
-0.7%
InnoCare Pharma
Market Cap: HK$34.9b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$17.70
7D
5.0%
1Y
216.6%
Nanjing Leads Biolabs
Market Cap: HK$12.7b
A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.
9887
HK$64.10
7D
-4.2%
1Y
n/a
Uni-Bio Science Group
Market Cap: HK$877.8m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.15
7D
-3.3%
1Y
77.1%
Shanghai Haohai Biological Technology
Market Cap: HK$11.7b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$26.76
7D
-4.7%
1Y
-16.5%
Keymed Biosciences
Market Cap: HK$20.9b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$71.00
7D
-6.9%
1Y
91.6%
HighTide Therapeutics
Market Cap: HK$2.3b
A clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and liver diseases in Mainland China.
2511
HK$4.02
7D
-3.1%
1Y
390.2%
Alphamab Oncology
Market Cap: HK$12.3b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.
9966
HK$12.66
7D
11.1%
1Y
348.9%
Mirxes Holding
Market Cap: HK$15.7b
A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.
2629
HK$59.75
7D
7.7%
1Y
n/a
Viva Biotech Holdings
Market Cap: HK$5.4b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$2.56
7D
2.0%
1Y
265.7%
Beijing Biostar Pharmaceuticals
Market Cap: HK$1.8b
A synthetic biology-driven biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology products in the People’s Republic of China.
2563
HK$8.33
7D
-2.7%
1Y
n/a
WuXi XDC Cayman
Market Cap: HK$94.2b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$76.75
7D
7.7%
1Y
275.3%
China Resources Pharmaceutical Group
Market Cap: HK$30.0b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.78
7D
-2.6%
1Y
-11.3%